Skip to content
10-Q

Quarterly Report

CLARUS THERAPEUTICS HOLDINGS, INC.

0001193125-22-224410

← back to feed
Filed
Aug 19, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 17, 2022 52.02M sh
Shares Diluted Q2 2022 · Jun 30, 2022 44.23M sh
Shares Diluted Q2 2022 · Jun 30, 2022 34.27M sh
Shares Diluted Q2 2022 · Jun 30, 2021 0 sh
Shares Diluted Q2 2022 · Jun 30, 2021 0 sh
Capex Q2 2022 · Jun 30, 2022 $10K
Capex Q2 2022 · Jun 30, 2021 $20K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$34.77M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$21.94M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $19.17M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $26.42M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$13.06M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$30.36M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$15.92M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$354.88M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$333.14M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 −$325.78M
Current Liabilities Q2 2022 · Jun 30, 2022 $61.81M
Current Liabilities Q2 2022 · Dec 31, 2021 $66.06M
Total Liabilities Q2 2022 · Jun 30, 2022 $62M
Total Liabilities Q2 2022 · Dec 31, 2021 $67.63M
Current Assets Q2 2022 · Jun 30, 2022 $48.88M
Current Assets Q2 2022 · Dec 31, 2021 $51.64M
Total Assets Q2 2022 · Jun 30, 2022 $48.94M
Total Assets Q2 2022 · Dec 31, 2021 $51.71M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.24
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.75
Eps Diluted Q2 2022 · Jun 30, 2021 $0.00
Eps Diluted Q2 2022 · Jun 30, 2021 $0.00
Eps Basic Q2 2022 · Jun 30, 2022 −$0.24
Eps Basic Q2 2022 · Jun 30, 2022 −$0.75
Eps Basic Q2 2022 · Jun 30, 2021 $0.00
Eps Basic Q2 2022 · Jun 30, 2021 $0.00
Rd Expense Q2 2022 · Jun 30, 2022 $1.23M
Rd Expense Q2 2022 · Jun 30, 2022 $2.11M
Rd Expense Q2 2022 · Jun 30, 2021 $606K
Rd Expense Q2 2022 · Jun 30, 2021 $1.82M
Net Income Q2 2022 · Jun 30, 2022 −$10.69M
Net Income Q2 2022 · Jun 30, 2022 −$25.56M
Net Income restated Q2 2022 · Jun 30, 2021 −$18.12M
Net Income restated Q2 2022 · Jun 30, 2021 −$33.55M
Gross Profit Q2 2022 · Jun 30, 2022 $2.89M
Gross Profit Q2 2022 · Jun 30, 2022 $6.24M
Gross Profit Q2 2022 · Jun 30, 2021 $2.23M
Gross Profit Q2 2022 · Jun 30, 2021 $4.19M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.16M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.82M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $554K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $921K
Revenue Q2 2022 · Jun 30, 2022 $4.05M
Revenue Q2 2022 · Jun 30, 2022 $8.06M
Revenue Q2 2022 · Jun 30, 2021 $2.78M
Revenue Q2 2022 · Jun 30, 2021 $5.11M